358 related articles for article (PubMed ID: 19293529)
1. Impact of psoriasis on quality of life in Iran.
Aghaei S; Moradi A; Ardekani GS
Indian J Dermatol Venereol Leprol; 2009; 75(2):220. PubMed ID: 19293529
[TBL] [Abstract][Full Text] [Related]
2. Reliability and validity of the Chinese version of the Psoriasis Disability Index (PDI) in Chinese patients with psoriasis.
He Z; Lu C; Ou A; Fang J; Wang D; Deng J; Zhang Z; Yu J
Health Qual Life Outcomes; 2012 Apr; 10():37. PubMed ID: 22500772
[TBL] [Abstract][Full Text] [Related]
3. Psychometric properties of the Chinese version of Dermatology Life Quality Index (DLQI) in 851 Chinese patients with psoriasis.
He Z; Lu C; Basra MK; Ou A; Yan Y; Li L
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):109-15. PubMed ID: 22145712
[TBL] [Abstract][Full Text] [Related]
4. Measuring quality of life in patients with psoriasis using the Arabic version for Morocco of the Dermatology Life Quality Index.
Khoudri I; Lamchahab FZ; Ismaili N; Senouci K; Hassam B; Abouqal R
Int J Dermatol; 2013 Jul; 52(7):795-802. PubMed ID: 23488573
[TBL] [Abstract][Full Text] [Related]
5. Validation of psoriasis disability index (PDI) questionnaire Sinhala version.
Liyanage A; Liyanage G; De Silva V; Akarawita J; Gunasekera C; Imafuku S; Lekamwasam S
Arch Dermatol Res; 2022 Jan; 314(1):61-69. PubMed ID: 33675385
[TBL] [Abstract][Full Text] [Related]
6. Utility of the Dermatology Life Quality Index at initiation or switching of biologics in real-life Japanese patients with plaque psoriasis: Results from the ProLOGUE study.
Imafuku S; Kanai Y; Murotani K; Nomura T; Ito K; Ohata C; Yamazaki F; Miyagi T; Takahashi H; Okubo Y; Saeki H; Honma M; Tada Y; Mabuchi T; Higashiyama M; Kobayashi S; Hashimoto Y; Seishima M; Kakuma T
J Dermatol Sci; 2021 Mar; 101(3):185-193. PubMed ID: 33495058
[TBL] [Abstract][Full Text] [Related]
7. Validation of a new tool to assess health-related quality of life in psoriasis: the PSO-LIFE questionnaire.
Dauden E; Herrera E; Puig L; Sánchez-Carazo JL; Toribio J; Caloto MT; Nocea G; Roset M; Lara N
Health Qual Life Outcomes; 2012 May; 10():56. PubMed ID: 22624984
[TBL] [Abstract][Full Text] [Related]
8. PSOdisk is a reliable, intuitive instrument for the evaluation of psychological distress, which strongly correlates with DLQI: a preliminary study.
Cozzani E; Linder D; Burlando M; Gallo F; Sampogna F; Bruzzone M; Tacchino C; Drago F; Parodi A
Eur J Dermatol; 2018 Jun; 28(3):332-337. PubMed ID: 29789272
[TBL] [Abstract][Full Text] [Related]
9. Psychometric properties of the Dermatology Life Quality Index (DLQI) in 900 Italian patients with psoriasis.
Mazzotti E; Barbaranelli C; Picardi A; Abeni D; Pasquini P
Acta Derm Venereol; 2005; 85(5):409-13. PubMed ID: 16159732
[TBL] [Abstract][Full Text] [Related]
10. Impact of active and stable psoriasis on health-related quality of life: the PSO-LIFE study.
Daudén E; Herrera E; Puig L; Sánchez-Carazo JL; Toribio J; Perulero N
Actas Dermosifiliogr; 2013 Oct; 104(8):685-93. PubMed ID: 23958428
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Changes in Psoriasis Area and Severity Index by Body Region on Quality of Life in Patients with Psoriasis.
Sojević Timotijević Z; Majcan P; Trajković G; Relić M; Novaković T; Mirković M; Djurić S; Nikolić S; Lazić B; Janković S
Acta Dermatovenerol Croat; 2017 Oct; 25(3):215-222. PubMed ID: 29252174
[TBL] [Abstract][Full Text] [Related]
12. DLQI scores in vitiligo: reliability and validity of the Persian version.
Aghaei S; Sodaifi M; Jafari P; Mazharinia N; Finlay AY
BMC Dermatol; 2004 Aug; 4():8. PubMed ID: 15294022
[TBL] [Abstract][Full Text] [Related]
13. Durable dermatology life quality index improvements in patients on biologics associated with psoriasis areas and severity index: a longitudinal study.
Chaptini C; Quinn S; Marshman G
Australas J Dermatol; 2016 Aug; 57(3):e72-5. PubMed ID: 26010650
[TBL] [Abstract][Full Text] [Related]
14. The Norwegian version of the dermatology life quality index: a study of validity and reliability in psoriatics.
Mørk C; Wahl A; Moum T
Acta Derm Venereol; 2002; 82(5):347-51. PubMed ID: 12430733
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the correlation between scales determining disease severity in patients with moderate-severe chronic plaque-type psoriasis.
Gundogdu M; Kundakci N
J Cosmet Dermatol; 2021 Jul; 20(7):2328-2331. PubMed ID: 33142051
[TBL] [Abstract][Full Text] [Related]
16. Psoriasis has a major secondary impact on the lives of family members and partners.
Eghlileb AM; Davies EE; Finlay AY
Br J Dermatol; 2007 Jun; 156(6):1245-50. PubMed ID: 17459044
[TBL] [Abstract][Full Text] [Related]
17. The impact of PASI 75 and PASI 90 on quality of life in moderate to severe psoriasis patients.
Abrouk M; Nakamura M; Zhu TH; Farahnik B; Koo J; Bhutani T
J Dermatolog Treat; 2017 Sep; 28(6):488-491. PubMed ID: 28042711
[TBL] [Abstract][Full Text] [Related]
18. Validation and application of the Dermatology Life Quality Index score, a modification of the DLQI score, in psoriasis patients.
Zou Q; Luo Y; Hao D; Li M; Jihui C
J Health Popul Nutr; 2024 Jun; 43(1):92. PubMed ID: 38909238
[TBL] [Abstract][Full Text] [Related]
19. Dermatology Life Quality Index (DLQI) scores in burn victims after revival.
Mazharinia N; Aghaei S; Shayan Z
J Burn Care Res; 2007; 28(2):312-7. PubMed ID: 17351451
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Skindex-29, Dermatology Life Quality Index, Psoriasis Disability Index and Medical Outcome Study Short Form 36 in patients with mild to severe psoriasis.
Fernandez-Peñas P; Jones-Caballero M; Espallardo O; García-Díez A
Br J Dermatol; 2012 Apr; 166(4):884-7. PubMed ID: 22229951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
